| COVID-19 |
1 |
1 |
| Cardiomyopathy |
0 |
0.9 |
| Myocarditis |
0 |
0.89 |
| Viral Myocarditis |
0 |
0.99 |
| Child |
0 |
0.98 |
| Pain Management |
0 |
0.32 |
| COVID-19 Vaccine |
0 |
0.27 |
| Adolescent Medicine |
0 |
0.26 |
| Vaccines |
0 |
0.25 |
| Cardiovascular Imaging |
0 |
0.18 |
| Chest Pain |
0 |
0.12 |
| Mechanical Ventilation |
0 |
0.12 |
| Arrhythmia |
0 |
0.11 |
| Angina Pectoris |
0 |
0.1 |
| Electrophysiology |
0 |
0.1 |
| Heart Failure (HF) |
0 |
0.1 |
| Biopsy |
0 |
0.07 |
| Cardiac MRI |
0 |
0.07 |
| Endomyocardial Biopsy |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Thorax |
0 |
0.07 |
| Echocardiography |
0 |
0.05 |
| ACE Inhibitor |
0 |
0.04 |
| Ejection Fraction |
0 |
0.04 |
| Fever |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Point-of-Care |
0 |
0.04 |
| Prognosis |
0 |
0.04 |
| Statistics |
0 |
0.04 |
| Stress |
0 |
0.04 |
| Texas |
0 |
0.04 |
| Transplantation |
0 |
0.04 |
| Triage |
0 |
0.04 |
| Ultrasonography |
0 |
0.04 |
| B-Type Natriuretic Peptide |
0 |
0.03 |
| Diarrhea |
0 |
0.03 |
| Hepatomegaly |
0 |
0.03 |
| Holter Monitor Testing |
0 |
0.03 |
| Interstitial Nephritis |
0 |
0.03 |
| Wound Management |
0 |
0.03 |
| Adenovirus |
0 |
0.02 |
| Bacteria |
0 |
0.02 |
| Brain |
0 |
0.02 |
| Centers for Disease Control and Prevention |
0 |
0.02 |
| Clinical Guidelines |
0 |
0.02 |
| Deep Venous Thrombosis |
0 |
0.02 |
| Epidemiology |
0 |
0.02 |
| Erectile Dysfunction |
0 |
0.02 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.02 |
| Fatigue |
0 |
0.02 |
| Hospitalists |
0 |
0.02 |
| Illinois |
0 |
0.02 |
| Immunization |
0 |
0.02 |
| Intensive Care Unit |
0 |
0.02 |
| Ischemia |
0 |
0.02 |
| Liver |
0 |
0.02 |
| Myocardial Infarction (MI) |
0 |
0.02 |
| Nephritis |
0 |
0.02 |
| Pericarditis |
0 |
0.02 |
| Pulmonary Embolism |
0 |
0.02 |
| Sedative |
0 |
0.02 |
| Serum Sickness |
0 |
0.02 |
| Troponin |
0 |
0.02 |
| Viral Infection |
0 |
0.02 |